Jenburkt Pharmaceuticals standalone net profit rises 46.65% in the September 2016 quarter

Sales rise 13.85% to Rs 28.61 crore
Net profit of Jenburkt Pharmaceuticals rose 46.65% to Rs 5.03 crore in the quarter ended September 2016 as against Rs 3.43 crore during the previous quarter ended September 2015. Sales rose 13.85% to Rs 28.61 crore in the quarter ended September 2016 as against Rs 25.13 crore during the previous quarter ended September 2015. ParticularsQuarter EndedSep. 2016Sep. 2015% Var.Sales28.6125.13 14 OPM %24.2620.89 -PBDT7.455.78 29 PBT7.005.31 32 NP5.033.43 47Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 22 2016 | 6:51 PM IST
